SciELO - Scientific Electronic Library Online

 
vol.28 número1Análisis de la capacidad de elección de alimentos saludables por parte de los consumidores en referencia a dos modelos de etiquetado nutricional: estudio cruzadoAsociación entre el índice inflamatorio-nutricional y estado nutricional en pacientes con cáncer índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

SANCHEZ-LARA, Karla; HERNANDEZ, Diego; MOTOLA, Daniel  y  GREEN, Dan. Association between overweight, glucocorticoids and metabolic syndrome in cancer patients under chemotherapy. Nutr. Hosp. [online]. 2013, vol.28, n.1, pp.182-187. ISSN 1699-5198.  http://dx.doi.org/10.3305/nh.2013.28.1.6177.

Metabolic syndrome components like overweight, obesity, insulin resistance, and hyperglycemia are common findings in patients with cancer diagnosis under chemotherapy treatment. These factors have been associated with higher recurrence rates. This study associates Body Mass index, steroids treatment and tumor site with metabolic syndrome (MS) components in patients with cancer diagnosis under chemotherapy treatment. Methods: In this retrospective study, files from patients under chemotherapy treatment treated in a university oncology center from 2008 to 2010 where reviewed. Anthropometric data and ATP III MS criteria were reviewed. Results: 158 patients were included, 75.9% female. Most common tumors were breast, gastrointestinal and lung cancer. 56.3% presented >3 component of MS; 43.6% of patients received Dexametasone as part of chemotherapy treatment. Mean BMI was 25.3 Kg/m2. Breast cancer diagnosis was associated with presence of 3 or more components of metabolic syndrome. Glococorticoid treatment was not significantly associated with MS diagnosis. Conclusions: patients with IMC>25 presented 12.6 more risk of MS, independently of glucocorticoids treatment. Weight maintenance is important to reduce MS.

Palabras clave : Cancer; Metabolic syndrome; Obesity; Glucocorticoids.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons